WEREWOLF THERAPEUTICS INC's ticker is HOWL and the CUSIP is 95075A107. A total of 51 filers reported holding WEREWOLF THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $4,321,000 | +10.3% | 958,125 | 0.0% | 0.09% | +6.2% |
Q2 2022 | $3,919,000 | -7.0% | 958,125 | 0.0% | 0.08% | -13.8% |
Q1 2022 | $4,216,000 | -63.1% | 958,125 | 0.0% | 0.09% | -60.7% |
Q4 2021 | $11,411,000 | -62.1% | 958,125 | -45.3% | 0.24% | -59.3% |
Q3 2021 | $30,078,000 | -32.4% | 1,752,787 | -31.3% | 0.59% | -25.8% |
Q2 2021 | $44,521,000 | – | 2,552,787 | – | 0.79% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DC Funds, LP | 589,102 | $10,274,000 | 48.81% |
MPM ASSET MANAGEMENT LLC | 4,284,172 | $74,716,000 | 13.89% |
MPM BioImpact LLC | 2,388,011 | $41,647,000 | 6.84% |
Soleus Capital Management, L.P. | 563,396 | $9,826,000 | 1.51% |
RA Capital Management | 4,291,881 | $74,850,000 | 1.20% |
SPHERA FUNDS MANAGEMENT LTD. | 706,294 | $12,049,000 | 0.82% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,552,787 | $44,521,000 | 0.79% |
Nicholas Investment Partners, LP | 294,654 | $5,139,000 | 0.32% |
Avidity Partners Management LP | 650,265 | $11,341,000 | 0.31% |
PFM Health Sciences, LP | 400,000 | $6,976,000 | 0.22% |